RISK FACTORS FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH CANCER TREATED WITH PONATINIB

被引:0
|
作者
Pei, Dorothy [1 ]
Ulhaq, Owais [1 ]
Go, Rafael [1 ]
Ali, Abdelrahman [1 ]
Khalaf, Shaden [1 ]
Hamzeh, Ihab [1 ]
Koutroumpakis, Efstratios [1 ]
Iliescu, Cezar [1 ]
Deswal, Anita [1 ]
Palaskas, Nicolas L. [1 ]
机构
[1] MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1252-044
引用
收藏
页码:2204 / 2204
页数:1
相关论文
共 50 条
  • [1] Risk factors for cardiovascular events in patients treated with immunotherapy.
    Garitaonaindia, Yago
    Blanco, Mariola
    Franco, Fernando
    Torrente, Maria
    Calvo, Virginia
    Collazo, Ana
    Del Alba, Aranzazu Gonzalez
    Cristobal Sanchez, Juan
    Gutierrez, Lourdes
    Royuela, Ana
    Nunez Garcia, Beatriz
    Mendez, Miriam
    Hernandez, Roberto
    Cantos Sanchez De Ibarguen, Blanca
    Martinez Cutillas, Marta
    Traseira, Cristina
    Aguado, Ramon
    Visedo Ceballos, Guillermo
    Provencio, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18736 - E18736
  • [2] Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab
    Ngo, Doan T. M.
    Williams, Trent
    Horder, Sophie
    Kritharides, Leonard
    Vardy, Janette
    Mandaliya, Hiren
    Nordman, Ina I. C.
    Lynam, James
    Bonaventura, Tony
    Sverdlov, Aaron L.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 9
  • [3] Factors associated with adverse cardiovascular events in cancer patients treated with Bevacizumab
    Williams, Trent
    Ngo, Doan T. M.
    Horder, Sophie
    Kritharides, Leonard
    Vardy, Janette
    Mandaliya, Hiren
    Nordman, Ina I. C.
    Lynam, James
    Bonaventura, Tony
    Sverdlov, Aaron L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 21 - 21
  • [4] Acquired and modifiable cardiovascular risk factors in patients treated for cancer
    Gary S. Beasley
    Jeffrey A. Towbin
    Journal of Thrombosis and Thrombolysis, 2021, 51 : 846 - 853
  • [5] Acquired and modifiable cardiovascular risk factors in patients treated for cancer
    Beasley, Gary S.
    Towbin, Jeffrey A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (04) : 846 - 853
  • [6] Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors
    Santoro, Marco
    Accurso, Vincenzo
    Mancuso, Salvatrice
    Contrino, Angelo Davide
    Sardo, Mariano
    Novo, Giuseppina
    Di Piazza, Florinda
    Perez, Alessandro
    Russo, Antonio
    Siragusa, Sergio
    CHEMOTHERAPY, 2020, 64 (04) : 205 - 209
  • [7] MAJOR ADVERSE CARDIOVASCULAR EVENTS: RISK FACTORS IN PATIENTS WITH RA TREATED WITH TOFACITINIB
    Charles-Schoeman, C.
    Valdez, H.
    Soma, K.
    Hwang, L.
    DeMasi, R.
    Boy, M.
    McInnes, I. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1034 - 1035
  • [8] Major Adverse Cardiovascular Events: Risk Factors in Patients with RA Treated with Tofacitinib
    Charles-Schoeman, Christina
    Valdez, Hernan
    Soma, Koshika
    Hwang, Lie-Ju
    DeMasi, Ryan
    Boy, Mary
    McInnes, Iain B.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] Analysis of the cardiovascular risk profile of Ph plus leukemia patients treated with ponatinib
    Khoury, Hanna Jean
    Cortes, Jorge E.
    Kim, Dong-Wook
    Pinilla-Ibarz, Javier
    Le Coutre, Philipp D.
    Paquette, Ronald
    Chuah, Charles
    Nicolini, Franck E.
    Apperley, Jane
    Talpaz, Moshe
    DiPersio, John F.
    DeAngelo, Daniel J.
    Abruzzese, Elisabetta
    Rea, Delphine
    Baccarani, Michele
    Mueller, Martin C.
    Gambacorti-Passerini, Carlo
    Lustgarten, Stephanie
    Yanase, Kumiko
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Cardiovascular Risk Factors and Events in Fibromyalgia Patients
    Atzeni, Fabiola
    Grillo, Mariateresa
    D'Amico, Valeria
    Rodriguez-Carrio, Javier
    Corda, Marco
    Alciati, Alessandra
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2023, 25 (09): : 627 - 630